TY - JOUR
T1 - Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3
AU - McCormick, James A.
AU - Yang, Chao Ling
AU - Zhang, Chong
AU - Davidge, Brittney
AU - Blankenstein, Katharina I.
AU - Terker, Andrew S.
AU - Yarbrough, Bethzaida
AU - Meermeier, Nicholas P.
AU - Park, Hae J.
AU - McCully, Belinda
AU - West, Mark
AU - Borschewski, Aljona
AU - Himmerkus, Nina
AU - Bleich, Markus
AU - Bachmann, Sebastian
AU - Mutig, Kerim
AU - Argaiz, Eduardo R.
AU - Gamba, Gerardo
AU - Singer, Jeffrey D.
AU - Ellison, David H.
PY - 2014/11/3
Y1 - 2014/11/3
N2 - Familial hyperkalemic hypertension (FHHt) is a monogenic disease resulting from mutations in genes encoding WNK kinases, the ubiquitin scaffold protein cullin 3 (CUL3), or the substrate adaptor kelch-like 3 (KLHL3). Disease-associated CUL3 mutations abrogate WNK kinase degradation in cells, but it is not clear how mutant forms of CUL3 promote WNK stability. Here, we demonstrated that an FHHt-causing CUL3 mutant (CUL3 Δ403-459) not only retains the ability to bind and ubiquitylate WNK kinases and KLHL3 in cells, but is also more heavily neddylated and activated than WT CUL3. In cells, activated CUL3 Δ403-459 depleted KLHL3, preventing WNK degradation, despite increased CUL3-mediated WNK ubiquitylation; therefore, CUL3 loss in kidney should phenocopy FHHt in murine models. As predicted, nephron-specific deletion of Cul3 in mice did increase WNK kinase levels and the abundance of phosphorylated Na-Cl cotransporter (NCC). Over time, however, Cul3 deletion caused renal dysfunction, including hypochloremic alkalosis, diabetes insipidus, and salt-sensitive hypotension, with depletion of sodium potassium chloride cotransporter 2 and aquaporin 2. Moreover, these animals exhibited renal inflammation, fibrosis, and increased cyclin E. These results indicate that FHHt-associated CUL3 Δ403-459 targets KLHL3 for degradation, thereby preventing WNK degradation, whereas general loss of CUL3 activity - while also impairing WNK degradation - has widespread toxic effects in the kidney.
AB - Familial hyperkalemic hypertension (FHHt) is a monogenic disease resulting from mutations in genes encoding WNK kinases, the ubiquitin scaffold protein cullin 3 (CUL3), or the substrate adaptor kelch-like 3 (KLHL3). Disease-associated CUL3 mutations abrogate WNK kinase degradation in cells, but it is not clear how mutant forms of CUL3 promote WNK stability. Here, we demonstrated that an FHHt-causing CUL3 mutant (CUL3 Δ403-459) not only retains the ability to bind and ubiquitylate WNK kinases and KLHL3 in cells, but is also more heavily neddylated and activated than WT CUL3. In cells, activated CUL3 Δ403-459 depleted KLHL3, preventing WNK degradation, despite increased CUL3-mediated WNK ubiquitylation; therefore, CUL3 loss in kidney should phenocopy FHHt in murine models. As predicted, nephron-specific deletion of Cul3 in mice did increase WNK kinase levels and the abundance of phosphorylated Na-Cl cotransporter (NCC). Over time, however, Cul3 deletion caused renal dysfunction, including hypochloremic alkalosis, diabetes insipidus, and salt-sensitive hypotension, with depletion of sodium potassium chloride cotransporter 2 and aquaporin 2. Moreover, these animals exhibited renal inflammation, fibrosis, and increased cyclin E. These results indicate that FHHt-associated CUL3 Δ403-459 targets KLHL3 for degradation, thereby preventing WNK degradation, whereas general loss of CUL3 activity - while also impairing WNK degradation - has widespread toxic effects in the kidney.
UR - http://www.scopus.com/inward/record.url?scp=84908631983&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84908631983&partnerID=8YFLogxK
U2 - 10.1172/JCI76126
DO - 10.1172/JCI76126
M3 - Article
C2 - 25250572
AN - SCOPUS:84908631983
SN - 0021-9738
VL - 124
SP - 4723
EP - 4736
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 11
ER -